Literature DB >> 14603422

Are national cardiac guidelines being applied by vascular surgeons?

K Cassar1, J J F Belch, J Brittenden.   

Abstract

INTRODUCTION: National cardiac guidelines recommend that patients with intermittent claudication should be managed in the same way as those with established coronary heart disease. This survey aimed to determine the attitudes of vascular consultants to risk factor management in new patients attending their out-patient clinic.
METHODS: An anonymous postal questionnaire was sent to all 394 members of the Vascular Surgical Society in June 2002. Questions were asked about the following measures: serum cholesterol levels, the presence of diabetes, antiplatelet therapy, exercise regimens, blood pressure, thrombophilia, smoking and the availability of local guidelines and expertise.
RESULTS: A response rate of 65% was obtained. Most (85%) consultants would measure a random cholesterol, but 34% would only treat claudicants if the cholesterol was greater than 5.5 mmol/l. Furthermore, 23% would inappropriately use diet alone as initial cholesterol lowering therapy. Over a quarter of consultants would not screen for diabetes or measure blood pressure. Nearly all (99%) would recommend aspirin and 66% would recommend nicotine replacement therapy. Only 55% had access to a smoking cessation clinic, and 34% to a formal exercise program. The majority (56%) did not have local risk factor management guidelines, only 16% had access to a vascular physician, and 65% would prefer to have this expertise available for difficult cases. DISCUSSION: Management of major risk factors was found to be sub-optimal. Thus guidelines for the prevention of coronary disease in clinical practice are not being applied to claudicants.

Entities:  

Mesh:

Year:  2003        PMID: 14603422     DOI: 10.1016/j.ejvs.2003.08.001

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  4 in total

1.  Smoking cessation counseling in vascular surgical practice using the results of interviews and focus groups in the Vascular Surgeon offer and report smoking cessation pilot trial.

Authors:  Karina Newhall; Mary Burnette; Benjamin S Brooke; Andres Schanzer; TzeWoei Tan; Susan Flocke; Alik Farber; Philip Goodney
Journal:  J Vasc Surg       Date:  2015-12-30       Impact factor: 4.268

2.  Suboptimal use of risk reduction therapy in peripheral arterial disease patients at a major teaching hospital.

Authors:  Mohammed Al-Omran; Subodh Verma; Thomas F Lindsay
Journal:  Ann Saudi Med       Date:  2011 Jul-Aug       Impact factor: 1.526

3.  Atherosclerotic disease and risk factor modification in Saudi Arabia: a call to action.

Authors:  Mohammed Al-Omran
Journal:  Vasc Health Risk Manag       Date:  2012-05-28

4.  Knowledge and attitude of physicians in a major teaching hospital towards atherosclerotic risk reduction therapy in patients with peripheral arterial disease.

Authors:  Mohammed Al-Omran
Journal:  Vasc Health Risk Manag       Date:  2007
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.